Research
Read how they describe their research on their University of Toronto profile.
Latest papers
The efficacy of mind-body (Baduanjin) exercise on self-reported sleep quality and quality of life in elderly subjects with sleep disturbances: a randomized controlled trial.
Sleep & breathing = Schlaf & Atmung · 2020
Bipolar disorders, type 2 diabetes mellitus, and the brain.
Current opinion in psychiatry · 2016
Bipolar disorder and ADHD: Clinical concerns.
CNS spectrums · 2009 · first author
Latest funding
- $1,510,875
Metformin for treatment-resistant bipolar depression (TRBD) with co-morbid insulin resistance (IR): A double-blind randomized control trial
CIHR · 2025 · Co-investigator
- $120,000
Metabolic Effects of Ketamine in Persons with Treatment-Resistant Depression: Potential Mechanism of Action and Characterizing Metabolic Biosignatures of Clinical Response
CIHR · 2025 · Supervisor
- $1,503,224
Adjunctive Psilocybin for Treatment Resistant Depression (Ad-Psilo): A Randomized, Active Placebo-Controlled, Phase II Clinical Trial
CIHR · 2025 · Co-investigator
3 publications.
The efficacy of mind-body (Baduanjin) exercise on self-reported sleep quality and quality of life in elderly subjects with sleep disturbances: a randomized controlled trial.
Fan B, Song W, Zhang J, Er Y, Xie B, Zhang H, Liao Y, Wang C, Hu X, Mcintyre R, Lee Y
Bipolar disorders, type 2 diabetes mellitus, and the brain.
Hajek T, McIntyre R, Alda M
Bipolar disorder and ADHD: Clinical concerns.
McIntyre R
Metformin for treatment-resistant bipolar depression (TRBD) with co-morbid insulin resistance (IR): A double-blind randomized control trial
Principal investigators: Hahn, Margaret; Agarwal, Sri Mahavir; Kloiber, Stefan M; Mansur, Rodrigo B; Saraf, Gayatri; Taylor, Valerie Hannah
Keywords: Bipolar Disorder; Depression; Insulin Resistance; Metformin; Treatment Resistance
Metabolic Effects of Ketamine in Persons with Treatment-Resistant Depression: Potential Mechanism of Action and Characterizing Metabolic Biosignatures of Clinical Response
Principal investigators: Wong, Sabrina
Keywords: Clinical Research; Glucose-Insulin Homeostasis; Glutamatergic Signaling; Homa-Ir; Insulin Signaling; Ketamine; Metabolism; Psychiatry; Psychopharmacology; Treatment-Resistant Depression
Adjunctive Psilocybin for Treatment Resistant Depression (Ad-Psilo): A Randomized, Active Placebo-Controlled, Phase II Clinical Trial
Principal investigators: Rosenblat, Joshua D; Husain, Muhammad I; Konstantinou, Gerasimos
Keywords: Clinical Trial; Drug Development; Major Depressive Disorder; Mood Disorders; Pharmacotherapy; Psilocybin; Psychedelics; Psychotherapy; Suicide; Treatment Resistant Depression
Combining Ketamine with Dialectical Behavioural Therapy (DBT) for Suicidality in Individuals with Treatment Resistant Depression and Borderline Personality Disorder: A Phase II Randomized, Midazolam-Controlled Clinical Trial
Principal investigators: Rosenblat, Joshua D; Burhan, Amer M; McMain, Shelley F
Keywords: Anesthesiology; Borderline Personality Disorder; Clinical Trial; Dialectical Behavioural Therapy; Ketamine; Major Depressive Disorder; Psychotherapy; Suicide; Treatment Resistant Depression
A Pilot Randomized Clinical Trial Comparing Psilocybin with Safety Monitoring Versus Psilocybin-Assisted Therapy for Treatment-Resistant Depression
Principal investigators: Husain, Muhammad I; Rosenblat, Joshua D
Keywords: Clinical Trial; Psilocybin
Psilocybin-assisted psychotherapy for cognitive impairment in treatment-resistant depression
Principal investigators: Johnson, Danica E
Keywords: Clinical Neuroscience; Cognitive Impairment; Neuropsychology; Psilocybin-Assisted Psychotherapy; Randomized Controlled Trial; Treatment-Resistant Depression
A Controlled Study of Extended Cannabis Abstinence in Major Depression
Principal investigators: George, Tony P; Kent, Pamela
Keywords: Abstinence; Cannabis; Cognition; Longitudinal Study; Major Depression; Randomized Study
Psilocybin-Assisted Psychotherapy for Treatment-Resistant Depression: A Randomized Phase II Clinical Trial Comparing One Versus Two Psychedelic Doses of Psilocybin
Principal investigators: Rosenblat, Joshua D; Gallson, Dave; Husain, Muhammad I
Keywords: Clinical Trial; Major Depressive Disorder; Mental Health; Psilocybin-Assisted Therapy; Psychiatry; Psychopharmacology; Psychotherapy; Treatment Resistant Depression
Integrated Internet-Based Cognitive Behavioural Therapy (i-CBT) and Intravenous Ketamine for Suicidality in Treatment-Resistant Depression: A Randomized, Midazolam-Controlled Clinical Trial
Principal investigators: McIntyre, Roger S; Rosenblat, Joshua D
Keywords: Cognitive Behavioural Therapy; Glutamate; Ketamine; Major Depressive Disorder; Nmda Antagonist; Psychopharmacology; Randomized Clinical Trial; Rapid Treatments; Suicide; Treatment-Resistant Depression
The Effect of Adjunctive Semaglutide Treatment on Reward Based Decision Making in Patients with Major Depressive Disorder
Principal investigators: Gill, Hartej
Keywords: Cognition; Depression; Metabolic Disorders; Mood And Anxiety Disorders; Obesity; Reward
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Psychiatry
- Department of Psychiatry
Co-authors at University of Toronto, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.
Profile data last refreshed on September 25, 2026 from the university directory, publication records and CIHR, NSERC and SSHRC funding.